Short Interest in Enzo Biochem, Inc. (NYSE:ENZ) Increases By 8.0%

Enzo Biochem, Inc. (NYSE:ENZ) was the target of a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 605,300 shares, a growth of 8.0% from the June 15th total of 560,500 shares. Approximately 1.7% of the company’s shares are sold short. Based on an average daily trading volume, of 132,100 shares, the short-interest ratio is presently 4.6 days.

Enzo Biochem Stock Performance

Shares of ENZ traded down $0.04 on Thursday, hitting $1.13. 102,107 shares of the stock traded hands, compared to its average volume of 111,675. The stock’s 50 day moving average is $1.11 and its two-hundred day moving average is $1.21. Enzo Biochem has a 1 year low of $0.99 and a 1 year high of $1.71.

Enzo Biochem (NYSE:ENZ) last announced its quarterly earnings data on Thursday, June 13th. The medical research company reported ($0.03) earnings per share (EPS) for the quarter. The firm had revenue of $8.02 million for the quarter. Enzo Biochem had a net margin of 134.17% and a negative return on equity of 21.50%.

Hedge Funds Weigh In On Enzo Biochem

A hedge fund recently bought a new stake in Enzo Biochem stock. FNY Investment Advisers LLC purchased a new position in shares of Enzo Biochem, Inc. (NYSE:ENZ) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 75,911 shares of the medical research company’s stock, valued at approximately $105,000. FNY Investment Advisers LLC owned 0.15% of Enzo Biochem as of its most recent SEC filing. Institutional investors own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.